MedPath

Comparison of Two drug, hyperbaric Levobupivacaine with hyperbaric Bupivacaine for spinal anesthesia, and to find out the drug having better efficacy in Elective Orthopedic Joint Replacement Surgeries.

Phase 3
Conditions
Health Condition 1: M171- Unilateral primary osteoarthritisof knee
Registration Number
CTRI/2024/01/062165
Lead Sponsor
Department of Anaesthesiology
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Elective joint replacement surgery patients of age 40 to 65 years

ASA Grade I and II.

Enrolled for elective joint replacement surgeries

Exclusion Criteria

Patient refusal

ASA Grade III or IV

Age below 40 or above 65 years

Infection at site of injection, any coagulopathy disorder or patients on anticoagulants, pre-existing neurological disease, psychological troubles, endocrinal disease

Morbid obesity.

Failure of spinal blockade.

Uncontrolled Diabetes, Hypertension, Chronic kidney disease, Chronic liver disease

Ischemic Heart Disease or other Cardiac illness

Patients with previous spinal surgery, kyphoscoliosis or any spinal deformity

Emergency surgeries.

Patients with known history of previous allergy to local anesthetic drugs, especially drugs under investigations

History of any neurological disease like Gullion-Burry syndrome, sub-acute combined degeneration of spinal cord etc.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath